Iron-dependent human platelet activation and hydroxyl radical formation: Involvement of protein kinase C

Circulation

Volumn 99, Issue 24, 1999, Pages 3118-3124

  Praticò, Domenico ^a   Pasin, Mehtap ^a   Barry, Orla P ^a   Ghiselli, Andrea ^b   Sabatino, Giuseppe ^a,c   Iuliano, Luigi ^a   Fitzgerald, Garret A ^a   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Free radicals; Platelets; Protein kinase C; Thromboxane

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; CATALASE; COLLAGEN TYPE 2; DEFEROXAMINE; DEOXYRIBOSE; HYDROXYL RADICAL; IRON; MANNITOL; PROTEIN KINASE C; SCAVENGER; THROMBOXANE B2; UREA;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CELL MEMBRANE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CORONARY ARTERY DISEASE; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LOCALIZATION; ERYTHROCYTE; FEMALE; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IRON CHELATION; IRON STORAGE; LIPID PEROXIDATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0033594957     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.99.24.3118     Document Type: Article

References (39)

1. Turitto VT, Baumgartner HR. Platelet interaction with subendothelium in a perfusion system: physical role of red blood cells. Microvasc Res. 1975; 9:335-344.
2. Turitto VT, Weiss HJ. Red blood cells: their dual role in thrombus formation. Science. 1980;207:541-543.
3. Fernandez F, Goudable C, Sie P, Ton-That H, Durand D, Sue JM, Boneu B. Low hematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Br J Haematol. 1985;59:139-148.
4. Cadroy Y, Hanson SR. Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model. Blood. 1990;75: 2185-2193.
5. Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest. 1991;87:571-580.
6. Valles J, Santos MT, Aznar J, Marcus AJ, Martinez-Sales V, Portoles M, Broekman MJ, Safier LB. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, ADP release, and recruitment. Blood. 1991;78:154-162.
7. Santos MT, Valles J, Aznar J, Marcus AJ, Broeken MJ, Safier LB. Prothrombotic effects of erythrocytes on platelet reactivity: reduction by aspirin. Circulation. 1997;95:63-68.
8. Violi F, Ghiselli A, Alessandri C, Frattaroli S, Iuliano L, Balsano F. Activation of platelet cyclooxygenase by red blood cells in vitro. N Engl J Med. 1985;313:1091-1092.
9. Born GV, Bergquist D, Arfors KE. Evidence for inhibition of platelet aggregation in blood by a drug effect on erythrocytes. Nature. 1976;259: 233-235.
10. Reimers RC, Sutera SP, Joist JH. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood. 1984;64:1200-1206.
11. Weiss HJ, Lages B, Hoffmann T, Turitto V. Correction of the platelet adhesion defect in d-storage pool deficient at elevated hematocrit: possible role of adenosine diphosphate. Blood. 1996;87:4214-4222.
12. Sakon M, Hawinger J. Mechanism triggering platelet hemostatic plug formation in vivo. Trans Assoc Am Physicians. 1984;97:311-318.
13. Cullen KJ, Stenhouse NS, Wearne KL. Raised haemoglobin and risk of cardiovascular disease. Lancet. 1981;2:1288-1289.
14. Salonen JT, Nyyssonen K, Korpela H, Tuomilheto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation. 1992;86: 803-811.
15. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F, for the Bruneck Study Group. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Circulation. 1997;96: 3300-3307.
16. Williams RE, Zweier JL, Flaherty JT. Treatment with desferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts. Circulation. 1991;83:1006-1014.
17. Dabbagh AJ, Shwaery GL, Keaney JF, Frei D. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit. Arterioscler Thromb Vasc Biol. 1997;17:2638-2645.
18. Reunamen A, Takkunen H, Knekt P, Seppanen R, Aromaa A. Body iron stores, dietary iron intake and coronary heart disease mortality. J Intern Med. 1995;238:223-230.
19. Iuliano L, Violi F, Pedersen JZ, Praticö D, Rotilio G, Balsano F. Free radical-mediated platelet activation by hemoglobin released from red blood cells. Arch Biochem Biophys. 1992;299:220-224.
20. Iuliano L, Pedersen JZ, Praticö D, Rotilio G, Violi F. Role of hydroxyl radicals in the activation of human platelets. Eur J Biochem. 1994;221: 695-704.
21. 2-reactive species activate primed platelets in human whole blood. Am J Physiol. 1993;264:H1582-H1587.
22. Praticö D, Iuliano L, Pulcinelli FM, Bonavita MS, Gazzaniga PP, Violi F. Hydrogen peroxide triggers activation of human platelet selectively exposed to non-aggregating concentrations of arachidonic acid and collagen. J Lab Clin Med. 1992;119:364-370.
23. Leo R, Praticö D, Pulcinelli FM, Ghiselli A, Pignatelli P, Colavita A, Iuliano L, FitzGerald GA, Violi F. Platelet activation by superoxide anion and hydroxyl radicals intrinsically generated by platelets that had undergone anoxia and then reoxygenated. Circulation. 1997;95:885-891.
24. Kazanietz MG, Areces LB, Bahador H, Mischak H, Goodnight J, Mushinski JF, Blumberg PM. Characterization of ligand and substrate specificity for the calcium-dependent and calcium-independent protein kinase C isozymes. Mol Pharmacol. 1993;44:298-307.
25. Szallasi Z, Smith CB, Pettit GR, Blumberg PM. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem. 1994;269:2118-2124.
26. Palumbo EJ, Sweatt JD, Chen S-J, Klann E. Oxidation-induced persistent activation of protein kinase C in hippocampal homogenate. Biochem Biophys Res Commun. 1992;187:1439-1445.
27. 2. Proc Natl Acad Sci U S A. 1997;94:11233-11237.
28. Zwaginga JJ, Ijsseldijk MJW, de Groot PG, Kooistra M, Vos J, van Es A, Koomans HA, Struyvenberg A, Sixma JJ. Treatment of uremic anemia with recombinant erythropoietin also reduces the defects in platelet adhesion and aggregation caused by uremic plasma. Thromb Hemost. 1991;66:638-647.
29. Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J. 1993;7: 516-522.
30. Rocca B, Ciabattoni G, Tartaglione R, Cortellazzo S, Barbui T, Patrono C, Landolfi R. Increased thromboxane biosynthesis in essential thrombocythemia. Thromb Haemost. 1995;74:1225-1229.
31. Ascherio A, Willet WC. Are body iron stores related to the risk of coronary heart disease? N Engl J Med. 1994;330:1152-1154.
32. McCord JM. Is iron sufficiency a risk factor in ischemic heart disease? Circulation. 1991;83:1112-1114.
33. Swain J, Gutteridge JM. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material. FEBS Lett. 1995;368:513-515.
34. Violi F, Iuliano L, Balsano F. Iron, platelet function, and coronary heart disease: a possible link? Circulation. 1993;88:805-806.
35. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
36. Pignatelli P, Pulcinelli FM, Lenti L, Cazzaniga P, Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood. 1998; 91:484-490.
37. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzvmol. 1990;186:1-85.
38. Iuliano L, Praticö D, Ghiselli A, Bonavita MS, Violi F. Superoxide dismutase triggers activation of "primed platelets." Arch Biochem Biophys. 1991;289:180-183.
39. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994; 334:793-795.